| Literature DB >> 30071007 |
Pan Zhang1,2, Justin S Rhodes3,4, Theodore Garland5, Sam D Perez3, Bruce R Southey2, Sandra L Rodriguez-Zas2,6,7.
Abstract
Mouse lines selectively bred for high voluntary wheel-running behavior are helpful models for uncovering gene networks associated with increased motivation for physical activity and other reward-dependent behaviors. The fact that multiple brain regions are hypothesized to contribute to distinct behavior components necessitates the simultaneous study of these regions. The goals of this study were to identify brain-region dependent and independent gene expression patterns, regulators, and networks associated with increased voluntary wheel-running behavior. The cerebellum and striatum from a high voluntary running line and a non-selected control line were compared. Neuropeptide genes annotated to reward-dependent processes including neuropeptide S receptor 1 (Npsr1), neuropeptide Y (Npy), and proprotein convertase subtilisin/kexin type 9 (Pcsk9), and genes implicated in motor coordination including vitamin D receptor (Vdr) and keratin, type I cytoskeletal 25 (Krt25) were among the genes exhibiting activity line-by-region interaction effects. Genes annotated to the Parkinson pathway presented consistent line patterns, albeit at different orders of magnitude between brain regions, suggesting some parallel events in response to selection for high voluntary activity. The comparison of gene networks between brain regions highlighted genes including transcription factor AP-2-delta (Tfap2d), distal-less homeobox 5 gene (Dlx5) and sine oculis homeobox homolog 3 (Six3) that exhibited line differential expression in one brain region and are associated with reward-dependent behaviors. Transcription factors including En2, Stat6 and Eomes predominated among regulators of genes that differed in expression between lines. Results from the simultaneous study of striatum and cerebellum confirm the necessity to study molecular mechanisms associated with voluntary activity and reward-dependent behaviors in consideration of brain region dependencies.Entities:
Mesh:
Year: 2018 PMID: 30071007 PMCID: PMC6072066 DOI: 10.1371/journal.pone.0201773
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Genes exhibiting significant (FDR-adjusted P-value < 0.01, minimum log2 (line fold change) > |1.25|) activity line-by-brain region interaction.
| Gene | Log2(Line Fold Change) | Line-by-region Interaction | |||
|---|---|---|---|---|---|
| Symbol | Name | CeCo-CeHi | StCo-StHi | P-value | FDR P-value |
| Krt25 | keratin, type I cytoskeletal 25 isoform X2 | -1.98 | 3.02 | 1.5E-09 | 2.3E-05 |
| Lamc2 | laminin subunit gamma-2 isoform X2 | 1.57 | -0.59 | 7.7E-09 | 5.9E-05 |
| Fam124a | protein FAM124A isoform X1 | -1.35 | 0.03 | 1.4E-08 | 7.1E-05 |
| Npsr1 | neuropeptide S receptor isoform X2 | -6.47 | -0.56 | 4.9E-08 | 1.9E-04 |
| Myo18b | unconventional myosin-XVIIIb isoform X1 | 1.40 | -1.02 | 1.4E-07 | 3.5E-04 |
| Vdr | vitamin D3 receptor | -3.37 | -0.39 | 2.0E-07 | 4.4E-04 |
| Rab37 | ras-related protein Rab-37 isoform 1 | 0.23 | 1.61 | 3.4E-07 | 6.5E-04 |
| Necab1 | N-terminal EF-hand calcium-binding protein 1 | -2.69 | -0.32 | 4.2E-07 | 7.1E-04 |
| Pcsk9 | proprotein convertase subtilisin/kexin type 9 precursor | 3.21 | 0.54 | 1.2E-06 | 1.8E-03 |
| Tifa | TRAF-interacting protein with FHA domain-containing protein A isoform X1 | -1.58 | -0.30 | 6.7E-06 | 6.0E-03 |
| Creb3l1 | cyclic AMP-responsive element-binding protein 3-like protein 1 | 1.40 | 0.20 | 1.0E-05 | 7.6E-03 |
| Col5a2 | collagen alpha-2(V) chain preproprotein | -0.26 | 1.31 | 1.2E-05 | 8.2E-03 |
| En2 | homeobox protein engrailed-2 | -0.31 | 1.54 | 1.3E-05 | 8.4E-03 |
| Cd300lf | CMRF35-like molecule 1 isoform X3 | -1.12 | -4.23 | 1.8E-05 | 1.1E-02 |
| Npy | pro-neuropeptide Y preproprotein | 1.28 | -0.11 | 1.9E-05 | 1.1E-02 |
1 CeCo-CeHi: cerebellum control versus selected high running line; StCo-StHi: striatum control versus selected high running line.
Clusters of informative Gene Ontology molecular functions (MF), biological processes (BP), and KEGG pathway categories including at least 5 genes exhibiting an interaction effect and enriched (FDR-adjusted P-value < 0.1) from the DAVID analysis.
| Cluster ES /Category | GO Identifier | Name | Count | P-value | FDR P-value |
|---|---|---|---|---|---|
| BP | GO:0007399 | nervous system development | 37 | 1.9E-05 | 5.0E-02 |
| BP | GO:0022008 | neurogenesis | 29 | 5.9E-05 | 5.3E-02 |
| BP | GO:0007420 | brain development | 18 | 7.2E-05 | 4.8E-02 |
| BP | GO:0031175 | neuron projection development | 18 | 8.6E-04 | 1.3E-01 |
| BP | GO:0021695 | cerebellar cortex development | 5 | 1.3E-03 | 1.5E-01 |
| BP | GO:0021587 | cerebellum morphogenesis | 4 | 7.0E-03 | 3.4E-01 |
| BP | GO:0021575 | hindbrain morphogenesis | 4 | 8.7E-03 | 3.7E-01 |
| BP | GO:0007610 | behavior | 17 | 1.1E-04 | 4.3E-02 |
| BP | GO:0044708 | single-organism behavior | 11 | 5.3E-03 | 3.0E-01 |
| BP | GO:0008344 | adult locomotory behavior | 5 | 9.6E-03 | 3.7E-01 |
| BP | GO:0007155 | cell adhesion | 25 | 1.2E-03 | 1.5E-01 |
| BP | GO:0071495 | cellular response to endogenous stimulus | 22 | 3.7E-04 | 8.0E-02 |
| BP | GO:0032870 | cellular response to hormone stimulus | 12 | 3.9E-03 | 2.6E-01 |
| BP | GO:1901653 | cellular response to peptide | 8 | 5.3E-03 | 3.0E-01 |
| BP | GO:0021953 | central nervous system neuron differentiation | 7 | 6.0E-03 | 3.1E-01 |
| BP | GO:0030900 | forebrain development | 8 | 4.4E-02 | 6.4E-01 |
Gene Ontology (GO) biological process (BP) and KEGG pathway categories enriched (FDR-adjusted P-value < 0.05) among the genes over-expressed in the CeCo-CeHi contrast detected using GSEA.
| Expression/Category | Identifier | Name | Gene Count | P-value | FDR P-value |
|---|---|---|---|---|---|
| KEGG | mmu00190 | oxidative phosphorylation | 99 | 0.0E+00 | 0.0E+00 |
| KEGG | mmu03010 | ribosome | 82 | 0.0E+00 | 0.0E+00 |
| BP | GO:0045333 | cellular respiration | 127 | 0.0E+00 | 3.7E-04 |
| KEGG | mmu05012 | Parkinson’s disease | 101 | 0.0E+00 | 2.2E-03 |
| KEGG | mmu05016 | Huntington’s disease | 146 | 0.0E+00 | 6.1E-02 |
Gene Ontology (GO) biological process (BP) and KEGG pathway categories enriched (FDR-adjusted P-value < 0.05) among the genes over- and under-expressed in the StCo-StHi contrast detected using GSEA.
| Expression/Category | Identifier | Name | Gene Count | P-value | FDR P-value |
|---|---|---|---|---|---|
| BP | GO:0006119 | oxidative phosphorylation | 73 | <1.0E-20 | 2.8E-03 |
| BP | GO:0045333 | cellular respiration | 129 | <0.0E+00 | 4.2E-03 |
| KEGG | mmu03010 | ribosome | 82 | 0.0E+00 | 5.6E-03 |
| BP | GO:0010575 | + regulation of vascular endothelial growth factor production | 18 | 0.0E+00 | 3.6E-02 |
Top informative genes exhibiting significant (FDR-adjusted P-value < 0.01, log2 (fold change) > |4|) differential expression between Control (Co) and high activity (Se) lines across brain regions.
| Symbol | Name | Log2(Co/Hi) | FDR P-value |
|---|---|---|---|
| Zfp33b | low quality protein: zinc finger protein 431-like | -4.46 | 3.76E-12 |
| Ms4a2 | high affinity immunoglobulin epsilon receptor subunit beta isoform c | 8.20 | 4.25E-11 |
| Hist1h2al | histone Cluster 1 H2A Family Member L | 5.06 | 1.26E-09 |
| Arhgap8& | rho GTPase-activating protein 8 isoform X2 | -5.13 | 1.61E-08 |
| Ms4a3 | membrane-spanning 4-domains subfamily A member 3 | 8.16 | 2.14E-08 |
| Cyp11a1 | cholesterol side-chain cleavage enzyme, mitochondrial isoform X1 | -5.29 | 2.82E-08 |
| Lipo2 | lipase, member O2 isoform X3 | 4.30 | 8.35E-08 |
| Gif | gastric intrinsic factor precursor | 8.25 | 2.02E-05 |
| Krt12 | keratin, type I cytoskeletal 12 | -4.44 | 6.49E-05 |
| Shox2 | short stature homeobox protein 2 isoform X1 | -5.34 | 0.0092 |
Fig 1Network of differential gene expression in the cerebellum.
Delineated nodes: framework genes that exhibited a line fold change difference between brain regions > |2| and an activity line-by-brain region interaction effect; red: under-expression in Hi and green: over-expression in Hi relative to Co. The size of the node and intensity of the color denote the magnitude of the fold change. Non-delineated nodes: genes that did not reach the differential criteria or connecting genes. Edges: known direct associations between the corresponding nodes.
Fig 2Network of differential gene expression in the striatum.
Delineated nodes: framework genes that exhibited a line fold change difference between brain regions > |2| and an activity line-by-brain region interaction effect; red: under-expression in Hi and green: over-expression in Hi relative to Co. The size of the node and intensity of the color denote the magnitude of the fold change. Non-delineated nodes: genes that did not reach the differential criteria or connecting genes. Edges: known direct associations between the corresponding nodes.
Lists top differentially expressed genes between the cerebellum (Ce) and the striatum (St) at FDR-adjusted P-value < 1.0 E-19 and log2(fold change) > |5|.
| Symbol | Name | log2(Ce/St) | P-value | FDR P-value |
|---|---|---|---|---|
| Homer3 | homer protein homolog 3 isoform X1 | 5.47 | 4.7E-24 | 3.6E-20 |
| Car8 | carbonic anhydrase-related protein | 7.09 | 4.7E-24 | 3.6E-20 |
| Cbln3 | cerebellin-3 precursor | 10.79 | 1.1E-23 | 5.5E-20 |
| Gabra6 | gamma-aminobutyric acid receptor subunit alpha-6 isoform X1 | 11.52 | 7.9E-23 | 2.4E-19 |
| Atp2a3 | sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform a | 5.67 | 7.3E-22 | 1.2E-18 |
| Foxg1 | forkhead box protein G1 | -9.40 | 7.6E-22 | 1.2E-18 |
| Pcp2 | Purkinje cell protein 2 isoform X2 | 10.48 | 2.1E-21 | 2.3E-18 |
| Rin1 | ras and Rab interactor 1 isoform X4 | -5.09 | 4.0E-21 | 3.3E-18 |
| Adora2a | adenosine receptor A2a isoform X2 | -7.40 | 4.8E-21 | 3.7E-18 |
| Fat2 | protocadherin Fat 2 isoform X2 | 11.20 | 5.2E-21 | 3.7E-18 |
| Arhgef33 | rho guanine nucleotide exchange factor 33 isoform X1 | 7.38 | 5.4E-21 | 3.7E-18 |
| Chrm4 | muscarinic acetylcholine receptor M4 | -5.93 | 6.4E-21 | 3.9E-18 |
| Cbln1 | cerebellin-1 precursor | 6.40 | 1.9E-20 | 9.3E-18 |
| Dbpht2 | DNA binding protein with his-thr domain | -5.21 | 2.0E-20 | 9.4E-18 |
Transcription factors over-represented (normalized enrichment score > 3.5, targeting > 15% of all the differentially expressed genes considered) among genes exhibiting interaction and line effect and identified by at least 2 motifs.
| Transcription factor | NES | Target Count | % | Motif/Track Count | Interaction Effect | Line Effect | |||
|---|---|---|---|---|---|---|---|---|---|
| P-value | FDR P-value | Log2(Co/Se) | P-value | FDR P -value | |||||
| Stat6 | 3.80 | 61 | 22.1 | 4 | 3.5E-01 | 8.5E-01 | 0.21 | 3.2E-02 | 1.7E-01 |
| En2 | 3.49 | 48 | 17.4 | 12 | 1.3E-05 | 8.4E-03 | -0.62 | 7.7E-04 | 1.6E-02 |
| Eomes | 3.49 | 42 | 15.2 | 2 | 1.3E-01 | 6.9E-01 | -1.10 | 1.6E-03 | 2.5E-02 |
1NES: normalized enrichment score or maximal enrichment score for a transcription factor
2 Number of target genes
3 Percentage of potential target genes out of all genes analyzed
4 Number of motifs per transcription factor
Fig 3Transcription factors enriched among the genes exhibiting line-by-region interaction or activity line main effect.
Triangles: transcription factors; ovals: target genes.